- Report
- February 2024
- 112 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 114 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 110 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €869EUR$875USD£723GBP
€1242EUR$1,250USD£1,033GBP
- Clinical Trials
- November 2024
- 60 Pages
Global
From €1490EUR$1,500USD£1,239GBP
- Report
- August 2024
- 238 Pages
Global
From €5529EUR$5,565USD£4,597GBP
€7898EUR$7,950USD£6,567GBP
- Report
- August 2024
- 207 Pages
Global
From €5529EUR$5,565USD£4,597GBP
€7898EUR$7,950USD£6,567GBP
- Report
- August 2024
- 60 Pages
Global
From €1043EUR$1,050USD£867GBP
€1490EUR$1,500USD£1,239GBP
- Clinical Trials
- August 2024
- 80 Pages
Global
From €1391EUR$1,400USD£1,156GBP
€1987EUR$2,000USD£1,652GBP
- Clinical Trials
- August 2024
- 60 Pages
Global
From €869EUR$875USD£723GBP
€1242EUR$1,250USD£1,033GBP
- Clinical Trials
- August 2024
- 240 Pages
Global
From €1739EUR$1,750USD£1,446GBP
€2484EUR$2,500USD£2,065GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 150 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 150 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Drug Pipelines
- July 2024
- 80 Pages
Global
From €1391EUR$1,400USD£1,156GBP
€1987EUR$2,000USD£1,652GBP
- Clinical Trials
- July 2024
- 80 Pages
Global
From €1391EUR$1,400USD£1,156GBP
€1987EUR$2,000USD£1,652GBP
- Clinical Trials
- July 2024
- 80 Pages
Global
From €1391EUR$1,400USD£1,156GBP
€1987EUR$2,000USD£1,652GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more